Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MIRA is 9.76M, and currently, shorts hold a 0.43% of that float. The average trading volume for MIRA on May 06, 2024 was 683.50K shares.
MIRA) stock’s latest price update
Mira Pharmaceuticals Inc (NASDAQ: MIRA)’s stock price has dropped by -9.27 in relation to previous closing price of 0.81. Nevertheless, the company has seen a loss of -14.75% in its stock price over the last five trading days. InvestorPlace reported 2024-03-08 that Mira Pharmaceuticals (NASDAQ: MIRA ) stock is rising on Friday after it provided investors with an interesting preclinical trial update. The company has been investigating its preclinical studies of MIRA1a.
MIRA’s Market Performance
Mira Pharmaceuticals Inc (MIRA) has experienced a -14.75% fall in stock performance for the past week, with a -28.14% drop in the past month, and a -21.18% drop in the past quarter. The volatility ratio for the week is 7.93%, and the volatility levels for the past 30 days are at 7.65% for MIRA. The simple moving average for the past 20 days is -17.26% for MIRA’s stock, with a -71.28% simple moving average for the past 200 days.
MIRA Trading at -29.11% from the 50-Day Moving Average
After a stumble in the market that brought MIRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -90.81% of loss for the given period.
Volatility was left at 7.65%, however, over the last 30 days, the volatility rate increased by 7.93%, as shares sank -28.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -30.85% lower at present.
During the last 5 trading sessions, MIRA fell by -14.75%, in comparison to the 20-day moving average, which settled at $0.8716. In addition, Mira Pharmaceuticals Inc saw -30.19% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MIRA starting from McNulty Brian Patrick, who sale 46,005 shares at the price of $1.55 back on Dec 11 ’23. After this action, McNulty Brian Patrick now owns 660,000 shares of Mira Pharmaceuticals Inc, valued at $71,496 using the latest closing price.
McNulty Brian Patrick, the 10% Owner of Mira Pharmaceuticals Inc, sale 19,053 shares at $1.61 during a trade that took place back on Dec 08 ’23, which means that McNulty Brian Patrick is holding 683,002 shares at $30,633 based on the most recent closing price.
Stock Fundamentals for MIRA
The total capital return value is set at -1.95.
Based on Mira Pharmaceuticals Inc (MIRA), the company’s capital structure generated 0.0 points at debt to capital in total, while cash flow to debt ratio is standing at -1112.92. The debt to equity ratio resting at 0.0. The interest coverage ratio of the stock is -2.47.
Currently, EBITDA for the company is -8.53 million with net debt to EBITDA at 0.54. The liquidity ratio also appears to be rather interesting for investors as it stands at 8.70.
Conclusion
In conclusion, Mira Pharmaceuticals Inc (MIRA) has had a bad performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
